Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D56WJV
|
|||
| Drug Name |
AAV-CNGB3
|
|||
| Drug Type |
Gene therapy
|
|||
| Indication | Achromatopsia [ICD-11: 9B70; ICD-10: H53.51] | Phase 1/2 | [1] | |
| Company |
MeiraGTx
|
|||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Cyclic nucleotide-gated channel beta-3 (CNGB3) | Target Info | . | [1] |
| KEGG Pathway | cAMP signaling pathway | |||
| Panther Pathway | Heterotrimeric G-protein signaling pathway-rod outer segment phototransduction | |||
| Pathway Interaction Database | Visual signal transduction: Cones | |||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Clinical pipeline report, company report or official report of MeiraGTx. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.